<![CDATA[ Health & Pharma ]]> en Sat, 09 May 2026 22:52:09 UTC <![CDATA[FDA Grants RMAT Designation to RZ-001, a Novel RNA Therapy for Hepatocellular Carcinoma]]> https://healthandpharma.net/fda-rmat-rz001-rna-therapy-hepatocellular-carcinoma-rznomics FDA & EMA Sat, 09 May 2026 21:34:21 UTC <![CDATA[FDA Approves Bizengri as First Targeted Therapy for NRG1 Fusion+ Cholangiocarcinoma]]> https://healthandpharma.net/fda-approves-bizengri-zenocutuzumab-cholangiocarcinoma FDA & EMA Sat, 09 May 2026 18:51:36 UTC <![CDATA[FDA Grants Fast Track Designation to RPTR-1-201 for Advanced Triple- Breast Cancer]]> https://healthandpharma.net/fda-fast-track-designation-rptr1-201-triple-breast-cancer FDA & EMA Fri, 08 May 2026 13:06:33 UTC <![CDATA[PHERGain Data Support Chemo-Free Treatment With 90% Five-Year RFS in Breast Cancer]]> https://healthandpharma.net/esmo-breast26-phergain-chemotherapy-free-survival-breast-cancer ONCOLife Thu, 07 May 2026 17:04:59 UTC <![CDATA[FDA Grants Fast Track Designation to Dubodencel for Advanced Cutaneous Melanoma]]> https://healthandpharma.net/fda-designation-dubodencel-doc1021-cutaneous-melanoma FDA & EMA Thu, 07 May 2026 00:52:16 UTC <![CDATA[Targeting RNase H2 Exposes a New Therapeutic Vulnerability in Triple-Negative Breast Cancer]]> https://healthandpharma.net/rnase-h2-exposes-triple-breast-cancer ONCOLife Wed, 06 May 2026 23:26:46 UTC <![CDATA[FDA Accepts IBTROZI sNDA After Durable Long-Term Benefit in Advanced ROS1+ Lung Cancer]]> https://healthandpharma.net/fda-taletrectinib-ibtrozi-snda-ros1-lung-cancer FDA & EMA Wed, 06 May 2026 22:10:22 UTC <![CDATA[ALK Mutation Emerges as a Potential Biomarker for Pan-Cancer Immunotherapy Benefit]]> https://healthandpharma.net/cancer-alk-mutation-immunotherapy-checkpoint-inhibitors ONCOLife Mon, 04 May 2026 23:27:41 UTC <![CDATA[FDA ODAC Backs Truqap Combination for PTEN-Deficient Metastatic Prostate Cancer]]> https://healthandpharma.net/fda-truqap-prostate-cancer-capivasertib FDA & EMA Sun, 03 May 2026 22:27:25 UTC <![CDATA[Zeta Navigation System Gains FDA Clearance for Brain Tumor Biopsy and Neurosurgery]]> https://healthandpharma.net/fda-ai-zeta-navigation-system-brain-tumor-biopsy-surgery FDA & EMA Sun, 03 May 2026 17:59:16 UTC <![CDATA[FDA Approves Vepdegestrant, First PROTAC Therapy for ESR1+ ER+/HER2- Breast Cancer]]> https://healthandpharma.net/fda-vepdegestrant-veppanu-breast-cancer FDA & EMA Sat, 02 May 2026 22:17:06 UTC <![CDATA[Misinformation Drives Over 16 Million Americans Toward High Skin Cancer Risk]]> https://healthandpharma.net/social-media-misinformation-skin-cancer-risk-sunscreen Clinical Trials Sat, 02 May 2026 13:45:00 UTC <![CDATA[SUNRISE-II Trial Begins Evaluating Ultrasound-Guided HIFU Ablation for Pancreatic Cancer]]> https://healthandpharma.net/suizenji-hifu-ablation-pancreatic-cancer Clinical Trials Fri, 01 May 2026 21:17:14 UTC <![CDATA[Restoring Proteostasis May Boost T Cell Function and Open a New Route for Immunotherapy]]> https://healthandpharma.net/restoring-proteostasis-boost-tcell-cancer-immunotherapy ONCOLife Thu, 30 Apr 2026 21:23:52 UTC <![CDATA[OPTIMAL Data Support TLX597-Tx as a Next-Gen Radioligand Therapy in Prostate Cancer]]> https://healthandpharma.net/tlx597tx-radioligand-therapy-prostate-cancer-telix Clinical Trials Wed, 29 Apr 2026 23:18:38 UTC <![CDATA[AidaBREAST Gains FDA Breakthrough Status for Personalized Radiotherapy in Breast Cancer]]> https://healthandpharma.net/aidabreast-test-fda-radiotherapy-breast-cancer FDA & EMA Wed, 29 Apr 2026 16:34:46 UTC <![CDATA[Phase 3 MagnetisMM-5 Trial Supports Earlier Use of Elranatamab in Relapsed Myeloma]]> https://healthandpharma.net/elranatamab-elrexfio-multiple-myelom-pfizer Clinical Trials Wed, 29 Apr 2026 14:07:00 UTC <![CDATA[Real-World Analysis Links Community Oncology Care to Longer Survival in Multi-Cancer]]> https://healthandpharma.net/community-oncology-care-survival-breast-lung-cancer ONCOLife Tue, 28 Apr 2026 14:24:07 UTC <![CDATA[Early CAR T-Cell Intervention Shows Disease-Eradication Potential in High-Risk Myeloma]]> https://healthandpharma.net/cart-cell-ciltacabtagene-smoldering-multiple-myeloma ONCOLife Mon, 27 Apr 2026 16:31:37 UTC <![CDATA[Dual Pathway Blockade Achieves 40% Response in Clear Cell Gynaecological Cancer]]> https://healthandpharma.net/pembrolizumab-lenvatinib-clear-cell-gynaecological-cancer Clinical Trials Mon, 27 Apr 2026 14:36:39 UTC <![CDATA[World’s First Nectin-4-Targeting ADC Enters Phase III Trial in Triple-Negative Breast Cancer]]> https://healthandpharma.net/nectin4-adc-breast-cancer-9mw2821-tnbc-mabwell Clinical Trials Sat, 25 Apr 2026 16:14:53 UTC <![CDATA[Long-Term Data Show Taletrectinib Delivers High Response Rates in ROS1+ NSCLC]]> https://healthandpharma.net/ibtrozi-taletrectinib-nsclc-lung-cancer ONCOLife Thu, 23 Apr 2026 21:34:42 UTC <![CDATA[FDA-Cleared Utepreva Device Aims to Improve Early Endometrial Cancer Detection]]> https://healthandpharma.net/fda-utepreva-device-endometrial-cancer-detection-test Cancer Thu, 23 Apr 2026 17:39:24 UTC <![CDATA[PLN-101095 Plus Pembrolizumab Shows Durable Responses in ICI-R Solid Tumors]]> https://healthandpharma.net/pln-101095-checkpoint-inhibitor-pembrolizumab-solid-tumors ONCOLife Wed, 22 Apr 2026 23:49:46 UTC <![CDATA[Opaganib Shows Dual Preclinical Promise in Neuroblastoma and Triple- Breast Cancer]]> https://healthandpharma.net/opaganib-neuroblastoma-breast-cancer ONCOLife Wed, 22 Apr 2026 22:05:28 UTC <![CDATA[Ozekibart Shows Encouraging Late-Line Activity in Metastatic Colorectal Cancer]]> https://healthandpharma.net/ozekibart-folfiri-metastatic-colorectal-cancer ONCOLife Wed, 22 Apr 2026 16:38:24 UTC <![CDATA[FDA Grants Breakthrough Status to First Viral Liquid Biopsy in Hepatocellular Carcinoma]]> https://healthandpharma.net/fda-breakthrough-viral-mrd-liquid-biopsy-hepatocellular-carcinoma FDA & EMA Wed, 22 Apr 2026 12:11:48 UTC <![CDATA[FDA Gives Priority Review to PADCEV Plus Pembrolizumab in MI Bladder Cancer]]> https://healthandpharma.net/fda-priority-padcev-pembrolizumab-mi-bladder-cancer FDA & EMA Mon, 20 Apr 2026 23:48:08 UTC <![CDATA[AACR26 Data Show Multi-Biomarker MCED Approach Improves Early Cancer Detection]]> https://healthandpharma.net/aacr2026-abbott-biomarker-mced-cancer-detection ONCOLife Sat, 18 Apr 2026 15:19:35 UTC <![CDATA[FDA Grants Breakthrough Status to First Urine-Based Multi-Cancer Early Detection Test]]> https://healthandpharma.net/fda-breakthrough-urine-cancer-detection-test-toby ONCOLife Fri, 17 Apr 2026 20:57:59 UTC <![CDATA[Daraxonrasib Doubles Overall Survival in Previously Treated Metastatic Pancreatic Cancer]]> https://healthandpharma.net/daraxonrasib-metastatic-pancreatic-cancer ONCOLife Thu, 16 Apr 2026 00:00:55 UTC <![CDATA[AI Nodule Detection Helps Sarasota Memorial Reach 75% Early Lung Cancer Diagnosis]]> https://healthandpharma.net/ai-nodule-detection-sarasota-memorial-lung-cancer AI Wed, 15 Apr 2026 21:05:54 UTC <![CDATA[Illumina Launch 100 K Genome Effort to Advance Cancer and Rare Disease Research]]> https://healthandpharma.net/illumina-d3b-genome-pediatric-cancer-rare-disease AI Wed, 15 Apr 2026 14:59:41 UTC <![CDATA[Zenocutuzumab Gains NCCN Support as FDA Review Advances in Cholangiocarcinoma]]> https://healthandpharma.net/bizengri-zenocutuzumab-fda-bla-cholangiocarcinoma FDA & EMA Wed, 15 Apr 2026 13:56:21 UTC <![CDATA[Phase 2 Data Position Trastuzumab Pamirtecan as a Promising Option in Endometrial Cancer]]> https://healthandpharma.net/biontech-trastuzumab-pamirtecan-her2-endometrial-cancer ONCOLife Tue, 14 Apr 2026 13:34:16 UTC <![CDATA[Mocertatug Rezetecan Shows Strong Responses in Ovarian and Endometrial Cancers]]> https://healthandpharma.net/gsk-mocertatug-rezetecan-ovarian-endometrial-cancers FDA & EMA Mon, 13 Apr 2026 20:32:51 UTC <![CDATA[FDA Grants Priority Review to Ifinatamab Deruxtecan in Pretreated ES-SC Lung Cancer]]> https://healthandpharma.net/fda-ifinatamab-deruxtecan-essc-lung-cancer FDA & EMA Mon, 13 Apr 2026 18:48:06 UTC <![CDATA[MD Anderson Study Identifies DPY30 as Therapeutic Target in Pancreatic Cancer]]> https://healthandpharma.net/md-anderson-dyp30-biomarker-target-pancreatic-cancer ONCOLife Mon, 13 Apr 2026 16:14:28 UTC <![CDATA[Blocking DHODH Helps Triple Combination Overcome Resistance in Lung Cancer]]> https://healthandpharma.net/dhodh-radiotherapy-lung-cancer-ferroptosis-leflunomide ONCOLife Sat, 11 Apr 2026 21:55:16 UTC <![CDATA[New Strategy Blocks NMD, Unmasks Hidden Tumor Antigens, and Boosts Immunotherapy]]> https://healthandpharma.net/blocks-nmd-hidden-tumor-immunotherapy-cancer ONCOLife Sat, 11 Apr 2026 16:43:09 UTC